Ola Soderquist - 31 Dec 2022 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CFO, 10%+ Owner
Signature
Ola Soderquist
Issuer symbol
BIXT
Transactions as of
31 Dec 2022
Transactions value $
-$38,681
Form type
5
Date filed
08 Feb 2023, 10:40
Previous filing
13 May 2022
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT common Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities -$2.68K -1.34M -100% $0.00* 0 31 Dec 2022 by NDPD Pharma, Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIXT warrant Gift -$36K -100K -100% $0.36 0 13 May 2022 common 100K $2.00 by NDPD Pharma, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 ownership of BIXT by NDPD Pharma, Inc. is consolidated under indirect ownership inside Davis Platt's filing